Bausch & Lomb Incorporated
Clinical trials sponsored by Bausch & Lomb Incorporated, explained in plain language.
-
New study monitors safety of special cataract lens after clouding treatment
Disease control Recruiting nowThis study is checking the safety of the IC-8 Apthera lens implant after treating a common side effect called posterior capsule opacification (PCO), where the lens capsule becomes cloudy. About 435 adults who already have this lens and develop PCO will be followed for up to 2 yea…
Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New eye drop cocktail aims to soothe dry eyes fast
Symptom relief Recruiting nowThis study tests a new eye drop that combines two existing medicines (lifitegrast and perfluorohexyloctane) for people with dry eye disease. About 423 adults with dry eyes for at least 6 months will use the drops twice a day for 4 weeks. The goal is to see if the combination work…
Phase: PHASE2 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC